Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Blackstone Leads $1.3 Billion Private Financing for Pharma Deal
Blackstone Inc. is leading a $1.3 billion financing backing the merger of pharmaceutical companies Paratek Pharmaceuticals Inc. and Radius Health Inc. As well as Blackstone Credit & Insurance, other firms that provided financing for the Paratek…
Don't Miss This 14% Yield And This Pharma Value Stock
Trinity Capital offers a 14% yield, trading at a discount with a diversified, largely secured portfolio and steady NII outpacing dividends. Bristol Myers Squibb is executing a portfolio transition, with growth drugs now 60% of sales and a robust…
Syndax Pharma: Two Drug Launches Fuel Transformational Growth (NASDAQ:SNDX)
Syndax Pharma delivered robust Q4 2025 results, with sales of $68.7 million (+794.5% YoY), driven by Revuforj and Niktimvo. Revuforj's rapid commercialization and label expansion position SNDX to access a $5 billion+ AML market, with 1L Phase 3…
FTC monitoring how Big Pharma reacts to patent cliffs
The FTC is closely observing blockbuster drugs approaching patent expiration to ensure generic entry and prevent anticompetitive practices. Blockbusters like Keytruda, Eliquis, Darzalex, Jakafi, Trulicity, Shingrix, Eylea, Ocrevus, and Farxiga are…
Gujarat pharma heavyweights Zydus, Torrent partner to co-market Semaglutide in India
In a collaboration between two Gujarat-based pharma majors, Zydus Lifesciences Limited and Torrent Pharmaceuticals Limited have entered into a licensing and supply agreement to co-market semaglutide injection in India, targeting diabetes and weight…
Mankind Pharma acquires Roche's Rivotril brand for India, bolsters CNS presence
Mankind Pharma has acquired Rivotril from Roche for the Indian market, with exclusive rights for domestic manufacture, marketing and distribution of the product, the company said. The acquisition bolsters Mankind's neurological products portfolio.
Mizuho Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target upped by stock analysts at Mizuho from $91.00 to $106.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has an 'outperform' rating on the stock.
UPDATE OF THE FINANCIAL CALENDAR FOR 2026
UPDATE OF THE FINANCIAL CALENDAR FOR 2026 Pharma Equity Group A/S updates its financial calendar for 2026. For technical reasons, the publication of the annual report is being postponed from 18 March 2026 to 25 March 2026. The date of the annual…
Peace through well-being: Orion and CMI - Martti Ahtisaari Peace Foundation announce partnership
Peace through well-being: Orion and CMI - Martti Ahtisaari Peace Foundation announce partnership Orion Corporation (“Orion Pharma”) and CMI - Martti Ahtisaari Peace Foundation (“CMI”) have entered a strategic content…
17 stocks including Tata Steel, SBI, Varun Beverages, Shree Cement, Wipro, Ceigall, NHPC, Paisalo, Strides Pharma will remain in focus on Wednesday
The board of Tata Steel has approved the merger of Neelachal Ispat Nigam Limited (NINL) with itself and an investment of up to US $2 billion in its wholly-owned subsidiary T Steel Holdings Pte Ltd. The board also cleared the acquisition of a stake…
Stock markets extend winning run to 3rd day
Stock market benchmark indices Sensex and Nifty ended nearly 1 per cent higher on Wednesday, extending their winning run to the third day in a row, amid a slight drop in crude oil prices and a firm trend in global peers. A rally in IT stocks also…
Courage, Crisis, and Creation: The Desh Bandhu Gupta Story
In ‘Made in India: The Story of Desh Bandhu Gupta, Lupin and Indian Pharma', co-author Manish Sabharwal chronicles the life of Lupin founder Desh Bandhu Gupta against the backdrop of India's pharmaceutical evolution. In this conversation, he…
Stock markets extend winning run to 3rd day; Sensex, Nifty climb nearly 1%
Indian stock markets surged, with Sensex and Nifty closing higher for the third consecutive day, driven by factors like falling crude oil prices and a robust IT sector performance. Sensex and Nifty indices closed nearly 1% higher, continuing a…
J&J wins approval for first-of-its-kind psoriasis pill
Johnson & Johnson won U.S. approval for a daily psoriasis pill that rivals the benefits of injectable medicines and could roil a multibillion-dollar market. The drug, Icotyde, is approved for patients over the age of 12 with moderate to severe…
Here's how much a remote per diem worker makes north of Boston
What is it like to live and/or work in one of the country's most expensive cities? We asked, and you answered. Greater Boston's economy is powered by workers from across industries, pay ranges, and job types: from baristas to software engineers…
Receive a Daily briefing on Pharma Industry News
Get Started